---
schema_version: "secwatch.filing_event.v1"
accession: "0001570562-22-000004"
form_type: "8-K"
ticker: "EOLS"
cik: "0001570562"
company_name: "Evolus, Inc."
filed_at: "2022-01-05T23:59:59+00:00"
generated_at: "2026-06-27T20:36:14.700554+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Evolus appoints Brady Stewart to Board of Directors effective Jan 5, 2022

## Summary
- Appointed Brady Stewart as Class II director, term expiring at 2023 annual meeting.
- Stewart receives RSUs valued at ~$230,000 vesting over 2 years, plus $42,000 annual retainer.
- Stewart is Chief Commercial Officer of Forma Brands, with 20+ years in digital/beauty DTC.

## SEC filing metadata
- accession: 0001570562-22-000004
- form_type: 8-K
- ticker: EOLS
- cik: 0001570562
- company_name: Evolus, Inc.
- filed_at: 2022-01-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1570562/000157056222000004/0001570562-22-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1570562/000157056222000004/eols-20220105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001570562-22-000004
- JSON: https://secwatch.observer/filing/0001570562-22-000004.json
- Plain text: https://secwatch.observer/filing/0001570562-22-000004.txt

## Key facts
- Executive change
  Brady Stewart was appointed as Director at Evolus, Inc..
  - Action: appointed
  - Role: Director
  source text: Effective January 5, 2022, the Board of Directors (the “Board”) of Evolus, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee (the “Committee”), appointed Brady Stewart as a member of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1570562/000157056222000004/0001570562-22-000004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.